CTBP1 and Alzheimer disease: By exploring the intricate mechanisms by which β-ARs influence AD pathology, this discussion aims to clarify their distinct functions relative to α-adrenergic receptors and highlight their potential as targets for precision medicine in neurodegenerative disorders.